Design, synthesis, and biological activity evaluation of 2-(benzo[b]thiophen-2-yl)-4-phenyl-4,5-dihydrooxazole derivatives as broad-spectrum antifungal agents
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 228, 113987
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New ApproachesCold Spring Harbor Perspectives in Medicine, 2014
- Aspergillus fumigatus—What Makes the Species a Ubiquitous Human Fungal Pathogen?PLOS Pathogens, 2013
- New Developments in Invasive Fungal DiseaseFuture Microbiology, 2012
- Review of Fluconazole Properties and Analytical Methods for Its DeterminationCritical Reviews in Analytical Chemistry, 2011
- Design, Synthesis, and in vitro Antifungal Activity of 1‐[(4‐Substituted‐benzyl)methylamino]‐2‐(2,4‐difluorophenyl)‐3‐(1H‐1,2,4‐triazol‐1‐yl)propan‐2‐olsChemMedChem, 2011
- Antifungals to treatCandida albicansExpert Opinion on Pharmacotherapy, 2010
- Emerging fungal infections among children: A review on its clinical manifestations, diagnosis, and preventionJournal of Pharmacy and Bioallied Sciences, 2010
- Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugsJournal of Pharmacy and Pharmacology, 2005
- Second-generation azole antifungal agentsDrugs of Today, 2005
- Echinocandin antifungal drugsThe Lancet, 2003